Star Combo Pharma Limited (ASX:S66)
Australia · Delayed Price · Currency is AUD 0.1400
0.00 (0.00%)
Sep 3, 2026, 4:10 PM AEST
Star Combo Pharma Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 19 | 18 | 18 | 15 | 15 | 21 | |
Market Cap Growth | -28.21% | 0% | 22.73% | 0% | -28.77% | -39.31% |
Enterprise Value | 5 | 4 | 9 | 10 | 10 | 10 |
Last Close Price | 0.14 | 0.14 | 0.13 | 0.11 | 0.11 | 0.15 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 47.93 | 46.21 | 3.47 | 19.88 | - | - |
PS Ratio | 0.80 | 0.77 | 0.66 | 0.57 | 0.60 | 0.91 |
PB Ratio | 0.49 | 0.47 | 0.48 | 0.44 | 0.45 | 0.59 |
P/TBV Ratio | 0.50 | 0.48 | 0.49 | 0.46 | 0.46 | 0.60 |
P/FCF Ratio | 22.99 | 22.17 | 1.58 | - | - | - |
P/OCF Ratio | 5.77 | 5.57 | 1.53 | - | 7.92 | 39.07 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.22 | 0.19 | 0.34 | 0.38 | 0.42 | 0.45 |
EV/EBITDA Ratio | 3.32 | 3.69 | 1.42 | 5.76 | 6.40 | 28.43 |
EV/EBIT Ratio | - | 455.18 | 1.88 | 10.80 | 9.28 | - |
EV/FCF Ratio | 6.19 | 5.47 | 0.82 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.11 | 0.11 | 0.10 | 0.12 | 0.13 | 0.12 |
Debt / EBITDA Ratio | 2.73 | 2.73 | 0.57 | 2.03 | 2.57 | 6.96 |
Debt / FCF Ratio | 5.09 | 5.09 | 0.34 | - | - | - |
Net Debt / Equity Ratio | -0.36 | -0.36 | -0.37 | -0.10 | -0.16 | -0.18 |
Net Debt / EBITDA Ratio | -11.33 | -11.33 | -2.14 | -1.92 | -3.25 | -17.13 |
Net Debt / FCF Ratio | -16.80 | -16.80 | -1.23 | 1.89 | 6.24 | 0.93 |
Asset Turnover | 0.48 | 0.48 | 0.61 | 0.61 | 0.58 | 0.53 |
Inventory Turnover | 4.24 | 4.24 | 3.81 | 3.85 | 4.16 | 3.81 |
Quick Ratio | 3.27 | 3.27 | 3.50 | 2.43 | 3.13 | 3.28 |
Current Ratio | 3.86 | 3.86 | 4.40 | 3.77 | 4.18 | 4.76 |
Return on Equity (ROE) | 1.02% | 1.02% | 14.63% | 2.24% | -11.66% | -1.94% |
Return on Assets (ROA) | 0.01% | 0.01% | 6.85% | 1.36% | 1.64% | -0.09% |
Return on Invested Capital (ROIC) | 0.03% | 0.03% | 18.21% | 2.37% | 3.93% | -0.25% |
Return on Capital Employed (ROCE) | 0.00% | 0.00% | 11.70% | 2.40% | 3.00% | -0.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 2.09% | 2.16% | 28.78% | 5.03% | -26.94% | -3.34% |
FCF Yield | 4.35% | 4.51% | 63.32% | -11.83% | -5.71% | -32.41% |
Dividend Yield | 2.11% | - | 2.79% | 3.50% | - | - |
Payout Ratio | 126.71% | 126.71% | 9.53% | - | - | - |
Buyback Yield / Dilution | - | - | - | - | -0.37% | 0.15% |
Total Shareholder Return | 2.11% | - | 2.79% | 3.50% | -0.37% | 0.15% |